There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CPC C07K16/2827
Jump to navigation
Jump to search
Pages in category "CPC C07K16/2827"
The following 37 pages are in this category, out of 37 total.
1
- 18277926. SINGLE DOMAIN ANTIBODY AGAINST PD-L1 AND USE THEREOF simplified abstract (SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION)
- 18294767. METHODS TO ENHANCE EFFICACY OF COMBINED TARGETING OF IMMUNE CHECKPOINT AND MAPK PATHWAYS (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18951146. BISPECIFIC HUMANIZED SINGLE DOMAIN ANTIBODY TO PD-L1 AND CD47, AND USE THEREOF (SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION)
A
C
G
S
T
- TAKEDA PHARMACEUTICAL COMPANY LIMITED Patent Application Trends in 2024
- THE ASAN FOUNDATION Patent Application Trends in 2025
- The Board of Trustees of the Leland Stanford Junior University Patent Application Trends in 2024
- The Johns Hopkins University Patent Application Trends in 2024
- The regents of the university of california (20250066480). METHODS TO ENHANCE EFFICACY OF COMBINED TARGETING OF IMMUNE CHECKPOINT AND MAPK PATHWAYS
- The Regents of The University Of California Patent Application Trends in 2024
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA Patent Application Trends in 2024
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA patent applications on February 27th, 2025
- Trustees of Dartmouth College Patent Application Trends in 2024
- TRUSTEES OF DARTMOUTH COLLEGE Patent Application Trends in 2025
